OSU and Nationwide Children’s reach deal on site for gene therapy manufacturing

Nationwide Children’s Hospital and the Ohio State University have agreed upon a west campus site for Andelyn Biosciences Inc.’s planned “$74 million biotechnology manufacturing facility for genetic material used in research and clinical trials,” Columbus Business First reports. The 8-acre site at Lane Avenue and Carmack Road “was identified in Columbus City Council documents for an economic incentive approved in February,” according to the article. Andelyn, a for-profit affiliate of Children’s, plans to build an 85,000-square-foot facility, and according to the proposed incentive, “pledged to create 170 new jobs” with an annual salary range of $69,000 to $280,000. For more, read the full article.

Economic Development, Financial Incentives, State Updates